BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 35171698)

  • 1. Oncosuppressive roles of decorin through regulation of multiple receptors and diverse signaling pathways.
    Xie C; Mondal DK; Ulas M; Neill T; Iozzo RV
    Am J Physiol Cell Physiol; 2022 Mar; 322(3):C554-C566. PubMed ID: 35171698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decorin in the Tumor Microenvironment.
    Baghy K; Reszegi A; Tátrai P; Kovalszky I
    Adv Exp Med Biol; 2020; 1272():17-38. PubMed ID: 32845500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decorin as a multivalent therapeutic agent against cancer.
    Neill T; Schaefer L; Iozzo RV
    Adv Drug Deliv Rev; 2016 Feb; 97():174-85. PubMed ID: 26522384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decorin has an appetite for endothelial cell autophagy.
    Neill T; Torres A; Buraschi S; Iozzo RV
    Autophagy; 2013 Oct; 9(10):1626-8. PubMed ID: 23989617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteoglycan neofunctions: regulation of inflammation and autophagy in cancer biology.
    Schaefer L; Tredup C; Gubbiotti MA; Iozzo RV
    FEBS J; 2017 Jan; 284(1):10-26. PubMed ID: 27860287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catabolic degradation of endothelial VEGFA via autophagy.
    Neill T; Chen CG; Buraschi S; Iozzo RV
    J Biol Chem; 2020 May; 295(18):6064-6079. PubMed ID: 32209654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decorin deficiency promotes hepatic carcinogenesis.
    Horváth Z; Kovalszky I; Fullár A; Kiss K; Schaff Z; Iozzo RV; Baghy K
    Matrix Biol; 2014 Apr; 35():194-205. PubMed ID: 24361483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decorin is a devouring proteoglycan: Remodeling of intracellular catabolism via autophagy and mitophagy.
    Buraschi S; Neill T; Iozzo RV
    Matrix Biol; 2019 Jan; 75-76():260-270. PubMed ID: 29080840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decorin activates AMPK, an energy sensor kinase, to induce autophagy in endothelial cells.
    Goyal A; Neill T; Owens RT; Schaefer L; Iozzo RV
    Matrix Biol; 2014 Feb; 34():46-54. PubMed ID: 24472739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncosuppressive functions of decorin.
    Neill T; Schaefer L; Iozzo RV
    Mol Cell Oncol; 2015; 2(3):e975645. PubMed ID: 27308453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decorin causes autophagy in endothelial cells via Peg3.
    Buraschi S; Neill T; Goyal A; Poluzzi C; Smythies J; Owens RT; Schaefer L; Torres A; Iozzo RV
    Proc Natl Acad Sci U S A; 2013 Jul; 110(28):E2582-91. PubMed ID: 23798385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Protective Role of Decorin in Hepatic Metastasis of Colorectal Carcinoma.
    Reszegi A; Horváth Z; Karászi K; Regős E; Postniková V; Tátrai P; Kiss A; Schaff Z; Kovalszky I; Baghy K
    Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32824864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor microenvironment: Modulation by decorin and related molecules harboring leucine-rich tandem motifs.
    Goldoni S; Iozzo RV
    Int J Cancer; 2008 Dec; 123(11):2473-9. PubMed ID: 18798267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decorin antagonizes corneal fibroblast migration via caveolae-mediated endocytosis of epidermal growth factor receptor.
    Mohan RR; Tripathi R; Sharma A; Sinha PR; Giuliano EA; Hesemann NP; Chaurasia SS
    Exp Eye Res; 2019 Mar; 180():200-207. PubMed ID: 30611736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decorin-mediated oncosuppression - a potential future adjuvant therapy for human epithelial cancers.
    Sainio AO; Järveläinen HT
    Br J Pharmacol; 2019 Jan; 176(1):5-15. PubMed ID: 29488209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation.
    Seidler DG; Goldoni S; Agnew C; Cardi C; Thakur ML; Owens RT; McQuillan DJ; Iozzo RV
    J Biol Chem; 2006 Sep; 281(36):26408-18. PubMed ID: 16835231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decorin antagonizes Met receptor activity and down-regulates {beta}-catenin and Myc levels.
    Buraschi S; Pal N; Tyler-Rubinstein N; Owens RT; Neill T; Iozzo RV
    J Biol Chem; 2010 Dec; 285(53):42075-85. PubMed ID: 20974860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decorin suppresses tumor lymphangiogenesis: A mechanism to curtail cancer progression.
    Mondal DK; Xie C; Pascal GJ; Buraschi S; Iozzo RV
    Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2317760121. PubMed ID: 38652741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Decorin Proteoglycan in Mitophagy.
    Neill T; Iozzo RV
    Cancers (Basel); 2022 Feb; 14(3):. PubMed ID: 35159071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decorin-mediated inhibition of proliferation and migration of the human trophoblast via different tyrosine kinase receptors.
    Iacob D; Cai J; Tsonis M; Babwah A; Chakraborty C; Bhattacharjee RN; Lala PK
    Endocrinology; 2008 Dec; 149(12):6187-97. PubMed ID: 18703624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.